Literature DB >> 15625575

Combined effects of radiotherapy and photodynamic therapy on an in vitro human prostate model.

Alberto Colasanti1, Annamaria Kisslinger, Maria Quarto, Patrizia Riccio.   

Abstract

Human prostate cancer cells were evaluated for growth after photodynamic therapy, radiotherapy, and combined treatment. Indocyanine green was tested as a photosensitizer and radiosensitizer. Two human cell lines were used: PC-3 derived from prostate carcinoma, and EPN derived from normal prostate tissue. The light source used for the photoactivation experiments was a diode laser peaked at 805 nm. The light dose incident on cells was 108 J/cm(2). Ionizing radiation was produced by a linear accelerator, and the dose was 2, 4 and 6 Gy. Cytotoxicity was evaluated by measuring the colony forming ability of cells. Our results show that indocyanine green induces cell death by photoactivation, but it does not act as a radiosensitizer if used with ionizing radiation. The combined treatment of photodynamic therapy and radiotherapy produces an additive effect which does not depend on the sequence of the two treatments. Combined treatments could be more useful since they allow the reduction of the ionizing radiation dose to obtain the same effect as one obtainable by radiotherapy alone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15625575     DOI: 0451041039

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  8 in total

1.  Assessing of integration of ionizing radiation with Radachlorin-PDT on MCF-7 breast cancer cell treatment.

Authors:  R Ghoodarzi; V Changizi; A R Montazerabadi; N Eyvazzadaeh
Journal:  Lasers Med Sci       Date:  2015-12-21       Impact factor: 3.161

2.  Photosensitizing and radiosensitizing effects of mitoxantrone: combined chemo-, photo-, and radiotherapy of DFW human melanoma cells.

Authors:  Ameneh Sazgarnia; Ali Reza Montazerabadi; Mohammad Hossein Bahreyni-Toosi; Amirhossein Ahmadi
Journal:  Lasers Med Sci       Date:  2013-02-01       Impact factor: 3.161

3.  Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs.

Authors:  J Hongrapipat; P Kopecková; S Prakongpan; J Kopecek
Journal:  Int J Pharm       Date:  2007-09-22       Impact factor: 5.875

4.  Neuroendocrine Tumor-Targeted Upconversion Nanoparticle-Based Micelles for Simultaneous NIR-Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging.

Authors:  Guojun Chen; Renata Jaskula-Sztul; Corinne R Esquibel; Irene Lou; Qifeng Zheng; Ajitha Dammalapati; April Harrison; Kevin W Eliceiri; Weiping Tang; Herbert Chen; Shaoqin Gong
Journal:  Adv Funct Mater       Date:  2017-01-17       Impact factor: 18.808

5.  Investigation of combined photodynamic and radiotherapy effects of gallium phthalocyanine chloride on MCF-7 breast cancer cells.

Authors:  Sara Mayahi; Ali Neshasteh-Riz; Majid Pornour; Samira Eynali; Alireza Montazerabadi
Journal:  J Biol Inorg Chem       Date:  2019-10-25       Impact factor: 3.358

Review 6.  Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy.

Authors:  Srivalleesha Mallidi; Sriram Anbil; Anne-Laure Bulin; Girgis Obaid; Megumi Ichikawa; Tayyaba Hasan
Journal:  Theranostics       Date:  2016-10-23       Impact factor: 11.556

7.  Mechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosis.

Authors:  Fiona M Frame; Huguette Savoie; Francesca Bryden; Francesca Giuntini; Vincent M Mann; Matthew S Simms; Ross W Boyle; Norman J Maitland
Journal:  Cancer Med       Date:  2015-11-21       Impact factor: 4.452

8.  Efficient cell death induction in human glioblastoma cells by photodynamic treatment with Tetrahydroporphyrin-Tetratosylat (THPTS) and ionizing irradiation.

Authors:  Peter Hambsch; Yury P Istomin; Dimitri A Tzerkovsky; Ina Patties; Jochen Neuhaus; Rolf-Dieter Kortmann; Stanislav Schastak; Annegret Glasow
Journal:  Oncotarget       Date:  2017-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.